DB17130InvestigationalCell transplant therapies
Spanlecortemlocel: Overview.
- Also known as
- Allogeneic umbilical cord blood (UCB) cell therapy product consisting of two cell fractions (CD34 enriched and CD34 depleted) derived from the same UCB unit · ALLOGENEIC UMBILICAL CORD BLOOD-DERIVED HEMATOPOIETIC STEM AND PROGENITOR CELLS MGTA-456 · EXPANDED UMBILICAL CORD BLOOD PRODUCT HSC835
- Code names
- HSC-835 · MGTA-456
Resolves to
Compound
What you can answer from here — as of April 23, 2025
Which companies are running trials of Spanlecortemlocel, in which indications and phases, and which of those programs are still active?
Create a free account or log in to explore the full data card.
Create Account